- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06687460
Distal Nerve Electrical Stimulation for Neuromuscular Reinnervation
April 12, 2026 updated by: National Cheng-Kung University Hospital
Brief Electrical Stimulation for Promoting Peripheral Nerve Regeneration After Primary Neurorrhaphy of Upper Extremities
During the process of nerve microsurgical reconstruction, 30 minutes of electrical stimulation is applied to the distal end of the damaged nerve to assess its potential benefits for nerve regeneration, functional recovery, slowing down the degeneration at the neuromuscular junction, and preventing muscle atrophy.
Study Overview
Status
Enrolling by invitation
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Taiwan
-
Tainan, Taiwan, Taiwan, 704302
- National Cheng Kung University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults aged 18 and older
- Acute peripheral nerve rupture between the elbow and wrist
- Acute rupture of the median or ulnar nerve
- Patients who have signed a valid written consent for surgery and trials
Patients with acute transection or compression of the median nerve or ulnar nerve resulting in impaired hand motor function.Patients with hand motor dysfunction secondary to nerve compression are defined as those who meet all of the following criteria:
- Evidence of muscle atrophy (including thenar muscles, hypothenar muscles, and interosseous muscles)
- Positive Froment's sign
- Positive Wartenberg's sign
- Presence of ape hand deformity
- Abnormal findings on electromyography (Needle EMG), such as abnormal insertional activity, increased spontaneous activity, or abnormal motor unit recruitment
- Classified as Grade IIA, IIB, or III according to the McGowan classification system for severity of nerve compression
Exclusion Criteria:
- History of injury or other causes leading to muscle and joint dysfunction in the affected area
- Patients with radial nerve damage
- Diabetes
- History of arrhythmia
- Stroke
- Multiple sclerosis
- Hereditary peripheral neuropathy
- Amyotrophic lateral sclerosis (ALS)
- Patients with a pacemaker
- Presence of local infection at the wound site
- Pregnant or breastfeeding women
- Patients deemed unsuitable for enrollment by a physician
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: nerve electrical stimulation
During the process of nerve microsurgical reconstruction, a 30-minute electric stimulation is applied to the distal end of the damaged nerve.
|
During the nerve micro-reconstruction surgery, electrical stimulation is given to the distal end of the damaged nerve for 30 minutes.
|
|
Placebo Comparator: nerve microsurgical reconstruction
no nerve electrical stimulation
|
only nerve microsurgical reconstruction, no nerve electrical stimulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NCV/EMG(CMAP,latency)
Time Frame: The third month after surgery.
|
The electromyography (EMG) is a diagnostic method used to assess muscle and nerve function, primarily to detect muscle activity and nerve conduction velocity, in order to monitor the recovery of neuromuscular function after surgery.
During the EMG examination, the examiner uses electrodes attached to the palm to measure and record the electrophysiological signals of the muscles for further analysis.
Through this method, doctors can evaluate the electrophysiological activity of the muscles to assess the reinnervation of distal muscles by the damaged nerves.
|
The third month after surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
DASH questionnaire
Time Frame: Preoperative (applicable to subjects with nerve compression), the first, third, and sixth months after surgery.
|
The DASH questionnaire (Disabilities of the Arm, Shoulder, and Hand) is a tool used to assess a patient's upper extremity function and symptoms.
It helps in evaluating the impact of musculoskeletal disorders on daily activities and quality of life.
|
Preoperative (applicable to subjects with nerve compression), the first, third, and sixth months after surgery.
|
|
Muscle power
Time Frame: Preoperative (applicable to subjects with nerve compression), the third and sixth months after surgery.
|
Muscle power refers to the ability of a muscle or group of muscles to exert force quickly.
It is a combination of strength and speed, and is often measured in activities that require explosive movements, such as sprinting, jumping, or lifting weights.
Muscle power is important for athletic performance and functional movement in daily activities.
|
Preoperative (applicable to subjects with nerve compression), the third and sixth months after surgery.
|
|
Purdue Pegboard test
Time Frame: Preoperative (applicable to subjects with nerve compression), the third and sixth months after surgery.
|
The Purdue Pegboard test is a standardized assessment used to measure manual dexterity and fine motor skills.
It involves placing pegs into holes on a board as quickly and accurately as possible, using one hand at a time and then both hands.
The test is commonly used in occupational therapy, rehabilitation, and research to evaluate hand function and coordination.
|
Preoperative (applicable to subjects with nerve compression), the third and sixth months after surgery.
|
|
MMDT
Time Frame: Preoperative (applicable to subjects with nerve compression), the third and sixth months after surgery
|
Assessment of hand dexterity and posture tolerance
|
Preoperative (applicable to subjects with nerve compression), the third and sixth months after surgery
|
|
NCV/EMG(CMAP,latency)
Time Frame: Preoperative (applicable to subjects with nerve compression) and the sixth month after surgery.
|
Electromyography (EMG) is a diagnostic method used to assess muscle and nerve function, primarily for detecting muscle activity and nerve conduction velocity to monitor the recovery of neuromuscular function post-surgery.
During an EMG examination, the examiner attaches electrodes to the palm to measure and record the electrophysiological signals of the muscles for further analysis.
This allows physicians to evaluate the electrophysiological activity of the muscles and assess the reinnervation of distal muscles by the damaged nerves.
|
Preoperative (applicable to subjects with nerve compression) and the sixth month after surgery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 12, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
November 5, 2024
First Submitted That Met QC Criteria
November 12, 2024
First Posted (Actual)
November 13, 2024
Study Record Updates
Last Update Posted (Actual)
April 15, 2026
Last Update Submitted That Met QC Criteria
April 12, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- A-BR-112-085
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.